发明申请
US20050272796A1 Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
审中-公开
预防和治疗良性前列腺增生使用罗丹明胺和罗丹明胺类似物
- 专利标题: Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
- 专利标题(中): 预防和治疗良性前列腺增生使用罗丹明胺和罗丹明胺类似物
-
申请号: US11171138申请日: 2005-06-29
-
公开(公告)号: US20050272796A1公开(公告)日: 2005-12-08
- 发明人: George Tidmarsh
- 申请人: George Tidmarsh
- 申请人地址: US CA Redwood City
- 专利权人: Threshold Pharmaceuticals, Inc.
- 当前专利权人: Threshold Pharmaceuticals, Inc.
- 当前专利权人地址: US CA Redwood City
- 主分类号: A61K
- IPC分类号: A61K20060101 ; A61K9/22 ; A61K31/415 ; A61K31/416 ; A61K31/70 ; A61P13/08 ; C12Q1/06 ; G01N33/567
摘要:
A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.